Millennium Management »

Aardvark Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.2M 320k 13.29
2025-03-31 $493k 66k 7.51

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Group
Adage Capital Partners GP
Millennium Management
BlackRock
Silverarc Capital Management
Schonfeld Strategic Advisors
Geode Capital Management
Cresset Asset Management
Cantor Fitzgerald, L. P.
State Street Corporation
Two Sigma Investments
Northern Trust

View all funds holding Aardvark Therapeutics